BridgeMD
Tests treatment safety and results for Stroke
Official title Effectiveness of a Home-Based Rehabilitation Program in Stroke Survivors Using the Euleria Home® Device
ClinicalTrials.gov ID: NCT06968923
What this study is testing
- What it's testing
- To verify the non-inferiority, in terms of post-treatment (T1) clinical effectiveness, of a "multidomain" telerehabilitation (TR) protocol compared to conventional outpatient rehabilitation in patients with stroke sequelae, with respect to motor, cognitive, and language functions. The absence of statistically significant differences between the two groups regarding treatment effects for each targeted domain will be considered an indicator of non-inferiority.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90
You may be able to join if
- Age over 18 years.
- First diagnosis of ischemic stroke, documented radiologically via CT or MRI scans, corresponding to ICD-9-CM codes 433 and 434 .
- Presence of aphasia, as assessed by the Aachener Aphasia Test (AAT), and/or cognitive deficits identified through the Oxford Cognitive Screen (OCS).
- Availability of an ADSL or higher-speed internet connection at the patient's residence.
- Ability of the patient and/or caregiver to understand and utilize the telerehabilitation system.
You likely can't join if
- Contemporanea partecipazione ad altri studi clinici;
- Decadimento cognitivo
- Deformità ossee come conseguenza di precedenti eventi traumatici ai 4 arti;
- Contratture fisse ai 4 arti valutate come 4/4 alla scala di Ashworth modificata (MAS)
- Altre patologie neurologiche e ortopediche in grado di interferire con lo studio.
See the full eligibility criteria
- Age over 18 years.
- First diagnosis of ischemic stroke, documented radiologically via CT or MRI scans, corresponding to ICD-9-CM codes 433 and 434 .
- Presence of aphasia, as assessed by the Aachener Aphasia Test (AAT), and/or cognitive deficits identified through the Oxford Cognitive Screen (OCS).
- Availability of an ADSL or higher-speed internet connection at the patient's residence.
- Ability of the patient and/or caregiver to understand and utilize the telerehabilitation system.
- Provision of written informed consent.
- Contemporanea partecipazione ad altri studi clinici;
- Decadimento cognitivo
- Deformità ossee come conseguenza di precedenti eventi traumatici ai 4 arti;
- Contratture fisse ai 4 arti valutate come 4/4 alla scala di Ashworth modificata (MAS)
- Altre patologie neurologiche e ortopediche in grado di interferire con lo studio.
The study team makes the final eligibility decision.
Where it's taking place
- Verona, verona, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Verona, verona, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.